Trial
NCT00271011
A Study of Mitomycin C, Irinotecan, and Cetuximab
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
—
Condition
Colorectal Cancer
Intervention
Mitomycin C
Why stopped
The study was discontinued due to the death of a co-investigator and a second co-investigator leaving the institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-03